NEWARK, Del. and
HYDERABAD, India, Jan. 26, 2011 /PRNewswire/ -- QPS, LLC, a leading
full-service GLP/GCP-compliant contract research organization
providing testing services to support preclinical and clinical
research and development, announced the acquisition of a majority
stake in Bioserve Clinical Research. Bioserve, a full service phase
1 CRO headquartered in Hyderabad,
India, will be known as QPS-Bioserve India.

QPS is a global CRO supporting drug discovery and
development since 1995. Its five areas of expertise include:
Preclinical DMPK/Tox, Bioanalytical, Translational Medicine, Early
Stage Clinical and Late Stage Clinical Research.

Bioserve is an ISO 9001:2008 certified organization
providing world-class clinical research services to sponsors across
the globe. Its infrastructure includes a 92-bed clinical unit for
conducting phase I studies and a bioanalytical lab equipped with
multiple LC/MS/MS systems for small molecule bioanalysis. Over the
past 6 years, it has conducted over 500 studies, with numerous
product approvals, and has been inspected by the USFDA, UK MHRA,
WHO and Indian DCGI.

"This new partnership further expands QPS' global range
of linearly integrated services," said Ben
Chien, PhD, Chairman, President and CEO of QPS. "With access
to Bioserve's additional resources, our customers will have the
heightened benefits of a third more phase I beds, bringing our
total to 400; greater bioanalytical capacity; and access to another
facility, located in India, with a
reputation for outstanding performance and a record of timely
approvals. Furthermore, current customers will be reassured to
learn that Mr. Suneil Reddy will
remain as Managing Director."

The company has been growing at a rate of over 50% per
year, with a current team of over 100 employees. Clients include
large Indian as well as Multinational pharmaceutical firms.
Bioserve's promoters - the founders of Vijaya Diagnostic Centre,
one of the largest diagnostic health care companies in India - bring a wealth of 30 years experience
in the healthcare and clinical domain, combined with a passion for
quality.

About QPS

QPS provides GLP/GCP-compliant preclinical and
clinical research services to pharmaceutical and biotechnology
clients worldwide in the areas of Bioanalysis, Drug Metabolism and
Pharmacokinetics, Translational Medicine, and Clinical Research.
Founded by Dr. Ben Chien in 1995,
QPS has Bioanalysis and Preclinical testing facilities at its
Newark, DE headquarters; in
Groningen, the Netherlands; and in
Taipei, Taiwan. Early-phase
clinical facilities are located in Springfield, MO; Taipei, Taiwan; and Groningen, the Netherlands. Business development
offices are maintained in the US, Europe, and Asia.